文献
J-GLOBAL ID:201802279500305326
整理番号:18A0471853
真核生物開始因子5A2はC Myc/microRNA29b軸を介してCD133(+)肝細胞癌細胞の維持に寄与する【Powered by NICT】
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis
著者 (19件):
Bai Hai-Yan
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Bai Hai-Yan
(Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China)
,
Liao Yi-Ji
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Cai Mu-Yan
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Cai Mu-Yan
(Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China)
,
Ma Ning-Fang
(Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, People’s Republic of China)
,
Zhang Qi
(Guangdong Provincial Key Laboratory of Liver Disease Research, The Third affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China)
,
Chen Jie-Wei
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Chen Jie-Wei
(Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China)
,
Zhang Jia-Xing
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Wang Feng-Wei
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Wang Chen-Yuan
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Chen Wen-Hui
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Jin Xiao-Han
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Xu Rui-Hua
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Guan Xin-Yuan
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Guan Xin-Yuan
(Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China)
,
Xie Dan
(State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China)
,
Xie Dan
(Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China)
資料名:
Stem Cells
(Stem Cells)
巻:
36
号:
2
ページ:
180-191
発行年:
2018年
JST資料番号:
A0655C
ISSN:
1066-5099
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)